Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Neurodon LLC
Profile last edited on: 10/2/2019      CAGE: 82D57      UEI: TH7KCXJBEJ35

Business Identifier: Biopharmaceuticals for small molecules that restore cellular homeostasis
Year Founded
2012
First Award
2018
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

9800 Rambling Rose Lane
Saint John, IN 46373
   (219) 779-7802
   N/A
   www.neurodon.net
Location: Single
Congr. District: 01
County: Lake

Public Profile

Neurodon LLC is a biopharmaceutical company focused on novel, clinically-relevant pathway with advanced programs in 4 sepcific therapeutic areas: medicines to improve memory and cognition in Alzheimer's Disease; therapeutics to cure akinesia in Parkinson't Disease; compounds for Diabetes IND-enabling studies; and molecules showing efficacy for stroke and traumatic brain injury. The company has expertise in small molecules that restore cellular homeostasis.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$225,000
Phase II Dollars
$1,989,595
Total Awarded
$2,214,595

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $2,743,724
Project Title: Optimization of Small Molecule SERCA2B Activators to Inhibit Neuron Loss in Alzheimer's Disease
0 1 NIH $286,348
Project Title: Preclinical evaluation of SERCA2 allosteric activators for pancreatic ?-cell protection in diabetes

Key People / Management

  Russell Dahl -- CEO and founder of Neurodon

  Colleen Mauger -- Research Coordinator

Company News

There are no news available.